Open Access
CC BY 4.0 · Indian J Med Paediatr Oncol 2024; 45(05): 439-442
DOI: 10.1055/s-0043-1775830
Case Report with Review of Literature

A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature

Authors

  • Rubi Gupta

    1   Department of Gynaecological Oncology, Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India
  • Pariseema Dave

    1   Department of Gynaecological Oncology, Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India
  • Bijal Patel

    1   Department of Gynaecological Oncology, Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India
  • Remi Abdul Shukur

    1   Department of Gynaecological Oncology, Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

Funding None declared.
Preview

Abstract

A synchronous solid and hematological malignancy is an uncommon condition in which a patient develops two or more primary cancers, one of which is a solid malignancy and the other one is a hematological malignancy, within 6 months of primary cancer diagnosis. The most common histology in solid malignancies is gastrointestinal adenocarcinoma, which coexists with the lymphoma subtype diffuse large B-cell lymphoma (DLBCL). Here, we report an extremely rare combination of serous carcinoma of the ovary synchronous with lymphoma of DLBCL subtype. A woman aged 52 years presented with an abdominal mass and abdominal pain for a short duration of 15 days. She was evaluated using clinical, radiological, and biochemical parameters. She was diagnosed with non-Hodgkin lymphoma by tru-cut biopsy from a bony lytic lesion and ovarian cancer by staging laparotomy. R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine, and prednisolone) chemotherapy for lymphoma and staging laparotomy for persistent adnexal mass resulted in complete remission of both ovarian cancer and lymphoma. She received paclitaxel and carboplatin-based postoperative chemotherapy as an adjuvant for ovarian cancer.

Patient Consent

During file release, general consent of the file includes that the biological content of the patient could be part of the research. Nondisclosure of a patient's identity, either in the form of name or photograph.




Publikationsverlauf

Artikel online veröffentlicht:
03. Oktober 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India